Literature DB >> 10766895

Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations.

P A Brex1, G J Parker, S M Leary, P D Molyneux, G J Barker, C A Davie, A J Thompson, D H Miller.   

Abstract

OBJECTIVES: Multiple sclerosis lesions appear as areas of high signal on T2 weighted MRI. A proportion of these lesions, when viewed on T1 weighted MRI, appear hypointense compared with surrounding white matter. These hypointense T1 lesions are thought to represent areas of greater tissue damage compared with the more non-specific, total T2 lesion load. This study aimed to better characterise the properties of high signal T2 lesions with differing appearances on T1 weighted MRI using quantitative MR techniques.
METHODS: Eleven patients with secondary progressive multiple sclerosis were studied. Two high signal T2 lesions were selected from each patient-one of which appeared hypointense and one isointense on a T1 weighted image. A voxel was positioned around each lesion and for this volume of brain the metabolite concentrations were estimated using proton MR spectroscopy ((1)H-MRS) and the T1 relaxation time within each voxel calculated from a T1 map generated using a multislice technique.
RESULTS: Compared with isointense T1 lesions, hypointense T1 lesions exhibited a significantly lower absolute concentration of N-acetyl derived metabolites (tNAA) and a significantly higher absolute concentration of myo-inositol (Ins). T1 relaxation time correlated significantly with both tNAA (r=-0.8, p < 0.001) and Ins (r=0.5, p=0. 012). There was no correlation between T1 relaxation times and creatine/phosphocreatine or choline containing compounds.
CONCLUSIONS: Prolonged T1 relaxation times seem to reflect the severity of axonal damage or dysfunction (inferred by a low tNAA) and possibly also gliosis (inferred by a high Ins) in chronic multiple sclerosis lesions.

Entities:  

Mesh:

Year:  2000        PMID: 10766895      PMCID: PMC1736901          DOI: 10.1136/jnnp.68.5.627

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  34 in total

1.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

Authors:  L Truyen; J H van Waesberghe; M A van Walderveen; B W van Oosten; C H Polman; O R Hommes; H J Adèr; F Barkhof
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

2.  Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease.

Authors:  H Kimura; R I Grossman; R E Lenkinski; F Gonzalez-Scarano
Journal:  AJNR Am J Neuroradiol       Date:  1996-09       Impact factor: 3.825

Review 3.  Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis.

Authors:  M Filippi; M A Horsfield; P S Tofts; F Barkhof; A J Thompson; D H Miller
Journal:  Brain       Date:  1995-12       Impact factor: 13.501

4.  1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis.

Authors:  C A Davie; G J Barker; A J Thompson; P S Tofts; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-12       Impact factor: 10.154

5.  Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

Authors:  J H Simon; L D Jacobs; M Campion; K Wende; N Simonian; D L Cookfair; R A Rudick; R M Herndon; J R Richert; A M Salazar; J J Alam; J S Fischer; D E Goodkin; C V Granger; M Lajaunie; A L Martens-Davidson; M Meyer; J Sheeder; K Choi; A L Scherzinger; D M Bartoszak; D N Bourdette; J Braiman; C M Brownscheidle; R H Whitham
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

6.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.

Authors:  P J Pouwels; J Frahm
Journal:  Magn Reson Med       Date:  1998-01       Impact factor: 4.668

7.  Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology.

Authors:  W Brück; A Bitsch; H Kolenda; Y Brück; M Stiefel; H Lassmann
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

8.  Chemical pathology of acute demyelinating lesions and its correlation with disability.

Authors:  N De Stefano; P M Matthews; J P Antel; M Preul; G Francis; D L Arnold
Journal:  Ann Neurol       Date:  1995-12       Impact factor: 10.422

9.  Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

Authors:  M A van Walderveen; F Barkhof; O R Hommes; C H Polman; H Tobi; S T Frequin; J Valk
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

10.  Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images.

Authors:  J F Hiehle; R I Grossman; K N Ramer; F Gonzalez-Scarano; J A Cohen
Journal:  AJNR Am J Neuroradiol       Date:  1995-01       Impact factor: 3.825

View more
  43 in total

Review 1.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

2.  Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types.

Authors:  H Vrenken; A Seewann; D L Knol; C H Polman; F Barkhof; J J G Geurts
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

3.  Cortical quantitative MRI parameters are related to the cognitive status in patients with relapsing-remitting multiple sclerosis.

Authors:  Alexandra van Wijnen; Franca Petrov; Michelle Maiworm; Stefan Frisch; Christian Foerch; Elke Hattingen; Helmuth Steinmetz; Johannes C Klein; Ralf Deichmann; Marlies Wagner; René-Maxime Gracien
Journal:  Eur Radiol       Date:  2019-10-10       Impact factor: 5.315

4.  Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.

Authors:  Ivan I Kirov; Shu Liu; Assaf Tal; William E Wu; Matthew S Davitz; James S Babb; Henry Rusinek; Joseph Herbert; Oded Gonen
Journal:  Hum Brain Mapp       Date:  2017-05-19       Impact factor: 5.038

5.  Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis.

Authors:  Belinda S Y Li; Juleiga Regal; Brian J Soher; Lois J Mannon; Robert I Grossman; Oded Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

6.  Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.

Authors:  René-Maxime Gracien; Sarah C Reitz; Stephanie Michelle Hof; Vinzenz Fleischer; Hilga Zimmermann; Amgad Droby; Helmuth Steinmetz; Frauke Zipp; Ralf Deichmann; Johannes C Klein
Journal:  Eur Radiol       Date:  2015-10-22       Impact factor: 5.315

7.  Quantitation of normal metabolite concentrations in six brain regions by in-vivoH-MR spectroscopy.

Authors:  Ludovico Minati; Domenico Aquino; Maria Grazia Bruzzone; Alessandra Erbetta
Journal:  J Med Phys       Date:  2010-07

8.  Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging.

Authors:  J Oh; R G Henry; C Genain; S J Nelson; D Pelletier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

9.  Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging study.

Authors:  Francesca Bagnato; Bing Yao; Fredric Cantor; Hellmut Merkle; Ellen Condon; Marcela Montequin; Sandra Moore; Martha Quezado; Deborah Tkaczyk; Henry McFarland
Journal:  J Neurol Sci       Date:  2009-04-23       Impact factor: 3.181

10.  1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage.

Authors:  Liat Ben Sira; Elka Miller; Moran Artzi; Aviva Fattal-Valevski; Shlomi Constantini; Dafna Ben Bashat
Journal:  Pediatr Radiol       Date:  2009-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.